A new state-of-the-art diagnostic test for animal African trypanosomiasis could detect sentinels of infection in domestic animals and aid control efforts.

While elimination of human African trypanosomiasis (HAT)—also known as sleeping sickness—is within reach across the continent, AAT remains a significant burden, with an estimated annual loss ...

Animal Trypanosomiasis remains a significant constraint to animal health and food security in most African countries. The COMBAT project, coordinated by the French Agricultural Research Center for ...

There are two forms of human African trypanosomiasis (HAT): one caused by Trypanosoma brucei gambiense, which is found in 24 countries across West and Central Africa and accounts for more than 92% ...

Guinea, a country in West Africa has successfully eradicated the gambiense form of human African trypanosomiasis (HAT) disease which is also known as sleeping sickness, says WHO. TheHealthSite.com ...

Dr. Tedros Adhanom Ghebreyesus, WHO Director-General Human African trypanosomiasis (HAT), or sleeping sickness, is a vector-borne parasitic disease caused by infected tsetse flies.

Note to the editor Human African trypanosomiasis, also known as sleeping sickness is a vector-borne parasitic disease caused by infection with protozoan parasites belonging to the genus Trypanosoma.

Sleeping sickness, or African trypanosomiasis, is emerging as a global health concern as scientists warn of its potential to spread beyond Africa. Traditionally confined to sub-Saharan Africa, the ...

Currently, no vaccine or prophylactic drug exists for African trypanosomiasis. Symptoms to spot The initial symptoms are fatigue, high fever, headaches, and muscle aches.

The World Health Organisation’s (WHO) technical advisory group on human African trypanosomiasis – commonly known as sleeping sickness – has confirmed that elimination by 2030 is within sight. Sleeping ...